(Q54657506)

2 June 2018

title

Protective role of peroxisome proliferator-activated receptor-β/δ in septic shock. (English)

1 reference

2 June 2018

1 reference

7

1 reference

2 June 2018

Roberto Fantozzi

9

1 reference

2 June 2018

Helder Mota-Filipe

11

1 reference

2 June 2018

Béatrice Desvergne

15

1 reference

2 June 2018

Christoph Thiemermann

17

object named as

Christoph Thiemermann

1 reference

2 June 2018

Muhammad Yaqoob Sharrudi

12

object named as

Muhammad M Yaqoob

1 reference

2 June 2018

Marcin Osuchowski

4

object named as

Marcin F Osuchowski

1 reference

2 June 2018

author name string

Amar Kapoor

1

1 reference

2 June 2018

Yasunori Shintani

2

1 reference

2 June 2018

Massimo Collino

3

1 reference

2 June 2018

Daniel Busch

5

1 reference

2 June 2018

Nimesh S A Patel

6

1 reference

2 June 2018

Sara Castiglia

8

1 reference

2 June 2018

David Bishop-Bailey

10

1 reference

2 June 2018

Ken Suzuki

13

1 reference

2 June 2018

Soheyl Bahrami

14

1 reference

2 June 2018

Jane A Mitchell

16

1 reference

2 June 2018

language of work or name

English

0 references

publication date

6 August 2010

1 reference

2 June 2018

American Journal of Respiratory and Critical Care Medicine

published in

1 reference

2 June 2018

volume

182

1 reference

2 June 2018

issue

12

1 reference

2 June 2018

page(s)

1506-1515

1 reference

2 June 2018

Cardiac dysfunction in sepsis: new theories and clinical implications.

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201002-0240OC

Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201002-0240OC

The steroid and thyroid hormone receptor superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201002-0240OC

Positive regulation of the peroxisomal beta-oxidation pathway by fatty acids through activation of peroxisome proliferator-activated receptors (PPAR)

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201002-0240OC

The cyclopentenone prostaglandin 15-deoxydelta(12,14)-prostaglandin J2 attenuates the development of zymosan-induced shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201002-0240OC

Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-gamma, reduces the development of nonseptic shock induced by zymosan in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201002-0240OC

PPARbeta/delta protects against experimental colitis through a ligand-independent mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201002-0240OC

Peroxisome proliferator-activated receptor beta/delta exerts a strong protection from ischemic acute renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201002-0240OC

Modulation of LPS-induced pulmonary neutrophil infiltration and cytokine production by the selective PPARbeta/delta ligand GW0742.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201002-0240OC

The PPARdelta agonist GW0742X reduces atherosclerosis in LDLR(-/-) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201002-0240OC

In vivo activation of peroxisome proliferator-activated receptor-delta protects the heart from ischemia/reperfusion injury in Zucker fatty rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201002-0240OC

Activation of peroxisome proliferator-activated receptor beta/delta inhibits lipopolysaccharide-induced cytokine production in adipocytes by lowering nuclear factor-kappaB activity via extracellular signal-related kinase 1/2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201002-0240OC

Sepsis and septic shock--a review of laboratory models and a proposal

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201002-0240OC

PPARdelta-mediated antiinflammatory mechanisms inhibit angiotensin II-accelerated atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201002-0240OC

Novel selective small molecule agonists for peroxisome proliferator-activated receptor delta (PPARdelta)--synthesis and biological activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201002-0240OC

Activation of peroxisome proliferator-activated receptor-beta/delta attenuates myocardial ischemia/reperfusion injury in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201002-0240OC

Identification and characterization of a selective peroxisome proliferator-activated receptor beta/delta (NR1C2) antagonist.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201002-0240OC

Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201002-0240OC

Suppression of Pro-inflammatory Adhesion Molecules by PPAR-δ in Human Vascular Endothelial Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201002-0240OC

The phosphoinositide 3-kinase pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201002-0240OC

Antiapoptotic role of PPARbeta in keratinocytes via transcriptional control of the Akt1 signaling pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201002-0240OC

Activation of nuclear hormone receptor peroxisome proliferator-activated receptor-delta accelerates intestinal adenoma growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201002-0240OC

Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201002-0240OC

Insulin action in cultured human myoblasts: contribution of different signalling pathways to regulation of glycogen synthesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201002-0240OC

Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201002-0240OC

GSK-3beta inhibitors attenuate the organ injury/dysfunction caused by endotoxemia in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201002-0240OC

The IKK/NF-kappa B pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201002-0240OC

Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201002-0240OC

PPARdelta modulates lipopolysaccharide-induced TNFalpha inflammation signaling in cultured cardiomyocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201002-0240OC

PPARalpha and PPARdelta activators inhibit cytokine-induced nuclear translocation of NF-kappaB and expression of VCAM-1 in EAhy926 endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201002-0240OC

Peroxisome proliferator-activated receptor beta/delta activation inhibits hypertrophy in neonatal rat cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201002-0240OC

STAT3 deletion during hematopoiesis causes Crohn's disease-like pathogenesis and lethality: a critical role of STAT3 in innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201002-0240OC

The PPARdelta agonist GW501516 suppresses interleukin-6-mediated hepatocyte acute phase reaction via STAT3 inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201002-0240OC

Emerging roles of peroxisome proliferator-activated receptor-beta/delta in inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201002-0240OC

10.1164/RCCM.201002-0240OC

21 January 2018

Identifiers

DOI

1 reference

2 June 2018

PubMed ID

20693380

1 reference

2 June 2018